Higher neighborhood disadvantage is associated with weaker interactions among cardiometabolic drivers

IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE
Joel Hernandez Sevillano , Masih A. Babagoli , Yitong Chen , Shelley H. Liu , Pranav Mellacheruvu , Janet Johnson , Borja Ibanez , Oscar Lorenzo , Jeffrey I. Mechanick
{"title":"Higher neighborhood disadvantage is associated with weaker interactions among cardiometabolic drivers","authors":"Joel Hernandez Sevillano ,&nbsp;Masih A. Babagoli ,&nbsp;Yitong Chen ,&nbsp;Shelley H. Liu ,&nbsp;Pranav Mellacheruvu ,&nbsp;Janet Johnson ,&nbsp;Borja Ibanez ,&nbsp;Oscar Lorenzo ,&nbsp;Jeffrey I. Mechanick","doi":"10.1016/j.ijcrp.2024.200322","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Adiposity, dysglycemia, and hypertension are metabolic drivers that have causal interactions with each other. However, the effect of neighborhood-level disadvantage on the intensity of interactions among these metabolic drivers has not been studied. The objective of this study is to determine whether the strength of the interplay between these drivers is affected by neighborhood-level disadvantage.</p></div><div><h3>Methods</h3><p>This cross-sectional study analyzed patients presenting to a multidisciplinary preventive cardiology center in New York City, from March 2017 to February 2021. Patients’ home addresses were mapped to the Area Deprivation Index to determine neighborhood disadvantage. The outcomes of interest were correlation coefficients (range from −1 to +1) among the various stages (0 - normal, 1 - risk, 2 - predisease, 3 - disease, and 4 - complications) of abnormal adiposity, dysglycemia, and hypertension at presentation, stratified by neighborhood disadvantage.</p></div><div><h3>Results</h3><p>The cohort consisted of 963 patients (age, median [IQR] 63.8 [49.7–72.5] years; 624 [65.1 %] female). The correlation among the various stages of adiposity, dysglycemia, and hypertension was weaker with increasing neighborhood disadvantage (P for trend &lt;0.001). Specifically, the correlation describing adiposity, dysglycemia, and hypertension interaction was weaker in the high neighborhood disadvantage group compared to the intermediate neighborhood disadvantage group (median [IQR]: 0.34 [0.27, 0.44] vs. median [IQR]: 0.39 [0.34, 0.45]; P &lt; 0.001) and compared to the low neighborhood disadvantage group (median [IQR]: 0.34 [0.27, 0.44] vs. median [IQR]: 0.54 [0.52, 0.57]; P &lt; 0.001), as well as weaker in the intermediate neighborhood disadvantage group compared to the low neighborhood disadvantage group (median [IQR]: 0.39 [0.34, 0.45] vs. 0.54 median [IQR]: 0.54 [0.52, 0.57]; P &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>Interactions among the various stages of abnormal adiposity, dysglycemia, and hypertension with each other are weaker with increasing neighborhood disadvantage. Factors related to neighborhood-level disadvantage, other than abnormal adiposity, might play a crucial role in the development of dysglycemia and hypertension.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"23 ","pages":"Article 200322"},"PeriodicalIF":1.9000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000874/pdfft?md5=cfe21e5ef0c759e4006c5ae46db78739&pid=1-s2.0-S2772487524000874-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cardiology Cardiovascular Risk and Prevention","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772487524000874","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Adiposity, dysglycemia, and hypertension are metabolic drivers that have causal interactions with each other. However, the effect of neighborhood-level disadvantage on the intensity of interactions among these metabolic drivers has not been studied. The objective of this study is to determine whether the strength of the interplay between these drivers is affected by neighborhood-level disadvantage.

Methods

This cross-sectional study analyzed patients presenting to a multidisciplinary preventive cardiology center in New York City, from March 2017 to February 2021. Patients’ home addresses were mapped to the Area Deprivation Index to determine neighborhood disadvantage. The outcomes of interest were correlation coefficients (range from −1 to +1) among the various stages (0 - normal, 1 - risk, 2 - predisease, 3 - disease, and 4 - complications) of abnormal adiposity, dysglycemia, and hypertension at presentation, stratified by neighborhood disadvantage.

Results

The cohort consisted of 963 patients (age, median [IQR] 63.8 [49.7–72.5] years; 624 [65.1 %] female). The correlation among the various stages of adiposity, dysglycemia, and hypertension was weaker with increasing neighborhood disadvantage (P for trend <0.001). Specifically, the correlation describing adiposity, dysglycemia, and hypertension interaction was weaker in the high neighborhood disadvantage group compared to the intermediate neighborhood disadvantage group (median [IQR]: 0.34 [0.27, 0.44] vs. median [IQR]: 0.39 [0.34, 0.45]; P < 0.001) and compared to the low neighborhood disadvantage group (median [IQR]: 0.34 [0.27, 0.44] vs. median [IQR]: 0.54 [0.52, 0.57]; P < 0.001), as well as weaker in the intermediate neighborhood disadvantage group compared to the low neighborhood disadvantage group (median [IQR]: 0.39 [0.34, 0.45] vs. 0.54 median [IQR]: 0.54 [0.52, 0.57]; P < 0.001).

Conclusions

Interactions among the various stages of abnormal adiposity, dysglycemia, and hypertension with each other are weaker with increasing neighborhood disadvantage. Factors related to neighborhood-level disadvantage, other than abnormal adiposity, might play a crucial role in the development of dysglycemia and hypertension.

较高的邻里劣势与较弱的心脏代谢驱动因素之间的相互作用有关
背景肥胖、血糖异常和高血压是代谢驱动因素,它们之间存在因果关系。然而,邻里层面的不利条件对这些代谢驱动因素之间相互作用强度的影响尚未得到研究。本研究的目的是确定这些驱动因素之间相互作用的强度是否会受到邻里水平劣势的影响。方法这项横断面研究分析了 2017 年 3 月至 2021 年 2 月期间到纽约市一家多学科预防心脏病中心就诊的患者。患者的家庭住址被映射到地区贫困指数(Area Deprivation Index)中,以确定社区的不利条件。研究结果为发病时不同阶段(0-正常、1-风险、2-疾病前、3-疾病和4-并发症)的异常脂肪、血糖异常和高血压之间的相关系数(范围从-1到+1),并按邻里劣势进行分层。结果队列由963名患者组成(年龄,中位数[IQR] 63.8 [49.7-72.5] 岁;624 [65.1%] 女性)。不同阶段的肥胖、血糖异常和高血压之间的相关性随着邻里劣势的增加而减弱(P为趋势<0.001)。具体来说,与中等邻里劣势组相比,高邻里劣势组中描述脂肪、血糖异常和高血压交互作用的相关性较弱(中位数 [IQR]:0.34 [0.27,0.001,0.002):0.34 [0.27, 0.44] vs. 中位数 [IQR]:0.39[0.34,0.45];P <0.001)和低邻里劣势组相比(中位数 [IQR]:0.34 [0.27,0.44] vs 中位数 [IQR]:0.39 [0.34,0.45];P <0.001):0.34 [0.27, 0.44] vs. 中位数 [IQR]:0.54[0.52,0.57];P <0.001),中等邻里劣势组与低邻里劣势组相比更弱(中位数 [IQR]:0.39 [0.34,0.57];P <0.001):0.39 [0.34, 0.45] vs. 0.54 中位数 [IQR]:结论不同阶段的异常脂肪、血糖异常和高血压之间的相互作用随着邻里劣势的增加而减弱。除了异常肥胖以外,与邻里劣势相关的因素可能在血糖异常和高血压的发展中起着至关重要的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
0
审稿时长
72 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信